339 related articles for article (PubMed ID: 28416441)
1. Glechoma hederacea extracts attenuate cholestatic liver injury in a bile duct-ligated rat model.
Wang YY; Lin SY; Chen WY; Liao SL; Wu CC; Pan PH; Chou ST; Chen CJ
J Ethnopharmacol; 2017 May; 204():58-66. PubMed ID: 28416441
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of rutin on liver injury induced by biliary obstruction in rats.
Pan PH; Lin SY; Wang YY; Chen WY; Chuang YH; Wu CC; Chen CJ
Free Radic Biol Med; 2014 Aug; 73():106-16. PubMed ID: 24815012
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats.
Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ
J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498
[TBL] [Abstract][Full Text] [Related]
4. Hepatoprotective activities of rosmarinic acid against extrahepatic cholestasis in rats.
Lin SY; Wang YY; Chen WY; Liao SL; Chou ST; Yang CP; Chen CJ
Food Chem Toxicol; 2017 Oct; 108(Pt A):214-223. PubMed ID: 28789951
[TBL] [Abstract][Full Text] [Related]
5. Chromium attenuates hepatic damage in a rat model of chronic cholestasis.
Chen WY; Chen CJ; Liao JW; Mao FC
Life Sci; 2009 Apr; 84(17-18):606-14. PubMed ID: 26324991
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of quercetin on cholestatic liver injury.
Lin SY; Wang YY; Chen WY; Chuang YH; Pan PH; Chen CJ
J Nutr Biochem; 2014 Nov; 25(11):1183-1195. PubMed ID: 25108658
[TBL] [Abstract][Full Text] [Related]
7. Targeting HMGB1/TLR4 axis and miR-21 by rosuvastatin: role in alleviating cholestatic liver injury in a rat model of bile duct ligation.
Nabih ES; El-Kharashi OA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jan; 392(1):37-43. PubMed ID: 30203151
[TBL] [Abstract][Full Text] [Related]
8. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
10. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
11. The antioxidant effect of green tea catechin ameliorates experimental liver injury.
Kobayashi H; Tanaka Y; Asagiri K; Asakawa T; Tanikawa K; Kage M; Yagi M
Phytomedicine; 2010 Mar; 17(3-4):197-202. PubMed ID: 20092986
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity.
Ahmadi A; Niknahad H; Li H; Mobasheri A; Manthari RK; Azarpira N; Mousavi K; Khalvati B; Zhao Y; Sun J; Zong Y; Ommati MM; Heidari R
Toxicol Lett; 2021 Oct; 349():12-29. PubMed ID: 34089816
[TBL] [Abstract][Full Text] [Related]
13. Plumbagin ameliorates bile duct ligation-induced cholestatic liver injury in rats.
Pan PH; Wang YY; Lin SY; Liao SL; Chen YF; Huang WC; Chen CJ; Chen WY
Biomed Pharmacother; 2022 Jul; 151():113133. PubMed ID: 35594710
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of the roots extract of Platycodon grandiflorum on bile duct ligation-induced hepatic fibrosis in rats.
Lim JH; Kim TW; Song IB; Park SJ; Kim MS; Cho ES; Jung JY; Son HY; Kim JW; Yun HI
Hum Exp Toxicol; 2013 Nov; 32(11):1197-205. PubMed ID: 23424213
[TBL] [Abstract][Full Text] [Related]
15. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol suppresses cholestasis-induced liver injury and fibrosis in rats associated with the inhibition of TGFβ1-Smad3-miR21 axis and profibrogenic and hepatic injury biomarkers.
ShamsEldeen AM; Al-Ani B; Ebrahim HA; Rashed L; Badr AM; Attia A; Farag AM; Kamar SS; Haidara MA; Al Humayed S; Ali Eshra M
Clin Exp Pharmacol Physiol; 2021 Oct; 48(10):1402-1411. PubMed ID: 34157155
[TBL] [Abstract][Full Text] [Related]
17. CGX, a multiple herbal drug, improves cholestatic liver fibrosis in a bile duct ligation-induced rat model.
Kim HG; Han JM; Lee HW; Lee JS; Son SW; Choi MK; Lee DS; Wang JH; Son CG
J Ethnopharmacol; 2013 Jan; 145(2):653-62. PubMed ID: 23228913
[TBL] [Abstract][Full Text] [Related]
18. Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats.
Zhong Z; Froh M; Lehnert M; Schoonhoven R; Yang L; Lind H; Lemasters JJ; Thurman RG
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1004-13. PubMed ID: 12791596
[TBL] [Abstract][Full Text] [Related]
19. Chromium attenuates hepatic damage in a rat model of chronic cholestasis.
Chen WY; Chen CJ; Liao JW; Mao FC
Life Sci; 2009 Apr; 84(17-18):606-14. PubMed ID: 19302800
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Effect of
Bae UJ; Park BH; Cho MK; Bae EJ
J Med Food; 2022 Jun; 25(6):652-659. PubMed ID: 35708629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
